Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The dual GLP-1/GIP agonist tirzepatide (Mounjaro/Zepbound) is showing superior metabolic outcomes to single-agonist GLP-1 agents in early PMOS-relevant data
Do NOT shake it
Strengthen the pelvic floor to treat incontinence and improve intimate wellness
Key Benefits Higher concentration for more efficient weekly dosing Smoother metabolic support with added B12 More affordable than our previous blend Smaller injection volume with the same or better weekly effect Consistent appetite and blood sugar support throughout the week Why We Chose This Formula This 34mg Tirzepatide / 1mg B12 / 2ml formula delivers a noticeably more concentrated profile, meaning your weekly injection works harder and more efficiently
Because of this, researchers frequently select peptide blends that can provide a broader research framework
US$ 28.46
US$ 24.58
US$ 22.79
US$ 26.20
US$ 23.16
US$ 25.68
US$ 20.34
US$ 21.71
US$ 21.97
US$ 27.50
